BIT 0.00% 3.0¢ biotron limited

Ann: Half Yearly Report and Accounts, page-51

  1. 19,103 Posts.
    lightbulb Created with Sketch. 5934
    Unless they can assess the science and put some probability on BIT landing a pharma partner to pay for the phase 3 trials then nobody has any idea. My estimate is the chance of this is just slightly above zero, but you would want to get the opinion of others.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.